ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC38066-50mg |
|
170569-88-7 |
Mavacoxib
|
0 | C16H11F4N3O2S | |
GC38066-25mg |
|
170569-88-7 |
Mavacoxib
|
0 | C16H11F4N3O2S | |
GC38066-10mg |
|
170569-88-7 |
Mavacoxib
|
0 | C16H11F4N3O2S | |
GC38066-5mg |
|
170569-88-7 |
Mavacoxib
|
0 | C16H11F4N3O2S | |
GC38066-1mg |
|
170569-88-7 |
Mavacoxib
|
0 | C16H11F4N3O2S | |
GC38065-10mg |
|
— |
Cardiotoxin Analog (CTX) IV (6-12) (TFA)
|
0 | C50H71F3N10O9 | |
GC38065-5mg |
|
— |
Cardiotoxin Analog (CTX) IV (6-12) (TFA)
|
0 | C50H71F3N10O9 | |
GC38065-1mg |
|
— |
Cardiotoxin Analog (CTX) IV (6-12) (TFA)
|
0 | C50H71F3N10O9 | |
GC38063-100mg |
|
900308-84-1 |
SEC inhibitor KL-1
|
0 | C18H16ClNO4 | |
GC38063-50mg |
|
900308-84-1 |
SEC inhibitor KL-1
|
0 | C18H16ClNO4 | |
GC38063-25mg |
|
900308-84-1 |
SEC inhibitor KL-1
|
0 | C18H16ClNO4 | |
GC38063-10mg |
|
900308-84-1 |
SEC inhibitor KL-1
|
0 | C18H16ClNO4 | |
GC38063-5mg |
|
900308-84-1 |
SEC inhibitor KL-1
|
0 | C18H16ClNO4 | |
GC38063-1mg |
|
900308-84-1 |
SEC inhibitor KL-1
|
0 | C18H16ClNO4 | |
GC38062-10mg |
|
173932-75-7 |
Gambogenic acid
|
0 | C38H46O8 | |
GC38062-5mg |
|
173932-75-7 |
Gambogenic acid
|
0 | C38H46O8 | |
GC38062-1mg |
|
173932-75-7 |
Gambogenic acid
|
0 | C38H46O8 | |
GC38060-100mg |
|
914805-33-7 |
Shield-1
|
0 | C42H56N2O10 | |
GC38060-50mg |
|
914805-33-7 |
Shield-1
|
0 | C42H56N2O10 | |
GC38060-25mg |
|
914805-33-7 |
Shield-1
|
0 | C42H56N2O10 | |